Rapid Micro Biosystems, Inc. (NASDAQ:RPID - Get Free Report)'s stock price shot up 3.6% on Monday . The company traded as high as $3.50 and last traded at $3.45. 71,484 shares traded hands during trading, a decline of 63% from the average session volume of 191,102 shares. The stock had previously closed at $3.33.
Wall Street Analyst Weigh In
Separately, KeyCorp began coverage on shares of Rapid Micro Biosystems in a report on Wednesday, February 12th. They set an "overweight" rating and a $8.00 target price for the company.
View Our Latest Stock Analysis on RPID
Rapid Micro Biosystems Trading Down 4.3%
The firm has a market cap of $156.48 million, a PE ratio of -3.19 and a beta of 1.13. The company's 50-day moving average is $2.65 and its 200 day moving average is $2.10.
Rapid Micro Biosystems (NASDAQ:RPID - Get Free Report) last issued its quarterly earnings results on Friday, May 9th. The company reported ($0.26) EPS for the quarter, beating the consensus estimate of ($0.27) by $0.01. The business had revenue of $7.21 million during the quarter, compared to the consensus estimate of $6.63 million. Rapid Micro Biosystems had a negative net margin of 184.93% and a negative return on equity of 48.05%. On average, research analysts predict that Rapid Micro Biosystems, Inc. will post -1.1 EPS for the current fiscal year.
Institutional Investors Weigh In On Rapid Micro Biosystems
Several hedge funds have recently made changes to their positions in RPID. ABG WTT Global Life Science Capital Partners GP Ltd lifted its position in shares of Rapid Micro Biosystems by 78.0% in the 1st quarter. ABG WTT Global Life Science Capital Partners GP Ltd now owns 1,848,296 shares of the company's stock valued at $4,880,000 after acquiring an additional 810,000 shares in the last quarter. Parkman Healthcare Partners LLC purchased a new stake in shares of Rapid Micro Biosystems in the 1st quarter valued at approximately $1,942,000. Informed Momentum Co LLC purchased a new stake in Rapid Micro Biosystems in the 1st quarter worth approximately $467,000. Evernest Financial Advisors LLC purchased a new stake in Rapid Micro Biosystems in the 1st quarter worth approximately $347,000. Finally, OMERS ADMINISTRATION Corp purchased a new stake in Rapid Micro Biosystems in the 1st quarter worth approximately $289,000. Hedge funds and other institutional investors own 52.60% of the company's stock.
Rapid Micro Biosystems Company Profile
(
Get Free Report)
Rapid Micro Biosystems, Inc, a life sciences technology company, provides products for the detection of microbial contamination in the manufacture of pharmaceutical, medical devices, and personal care products in the United States, Germany, Switzerland, Japan, and internationally. The company offers Growth Direct platform, which includes Growth Direct system, proprietary consumables, lab information management system connection software, and customer support and validation services.
Featured Articles
Before you consider Rapid Micro Biosystems, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Rapid Micro Biosystems wasn't on the list.
While Rapid Micro Biosystems currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
